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Inflammatory myofibroblastic tumors are rare, and those located in the extremities without bone involvement are
even rarer. We present the case of a 61-year-old Chinese male patient with an inflammatory myofibroblastic tumor
of the right thigh. It was excised and a histopathologic examination revealed an inflammatory myofibroblastic
tumor. This case is presented by virtue of its rare location.
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Inflammatory myofibroblastic tumor (IMT) is an uncom-
mon benign neoplasm with partially invasive behavior and
a tendency to recur [1]. IMTs are commonly found in the
lung [2-4]. Extrapulmonary IMTs occur in nearly every
site in the body, however, it is unusual for IMTs to exist in
the lower extremities without bone involvement [1,3-5].
Herein, we illustrate an unusual case of an IMT of the
thigh without bone involvement.Case presentation
A 61-year-old Chinese male patient was referred to our
service with a history of severe pain in his right thigh
for the most recent 18 months. There was no history of
trauma. A physical examination revealed a moderately
hard, immovable, and painful 150 × 100 mm mass of the
posterior thigh.
A magnetic resonance imaging (MRI) scan revealed a
lesion in the right side of the adductor magnus muscle.
The lesion was inhomogeneously isointense on the T1-
weighted images (Figure 1A, B) and the T2-weighted
image (Figure 2C), and inhomogeneously hyperintense on
the short TI inversion-recovery (STIR) images (Figure 1C, D)
with marked contrast enhancement after administra-
tion of gadolinium (Figure 2A, B). Further examina-
tions of contrast-enhanced MRI scans of the brain and* Correspondence: hlyangsuzhou@gmail.com
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of metastases.
The histologic findings of the biopsy performed before
the operation suggested a spindle cell tumor with mild
atypia. Subsequently, an excision of the tumor was
performed. A microscopic examination showed spindle
tumor cells arranged in an irregular pattern with variable
cell density. The tumor was infiltrated by some lympho-
cytes and a few neutrophil granulocytes (Figure 3A). The
spindle cells showed mild atypia and no mitoses were ob-
served. It was revealed on immunohistochemistry that the
tumor showed positive immunoreactivity for vimentin, α-
smooth muscle actin (α-SMA), and CD68 (Figure 3B, C, D),
but was negative for anaplastic lymphoma kinase (ALK),
S-100, CD34, CD117, kinesin-like protein-1 (KP-1), myelin
basic protein (MBP), and desmin. The patient’s recovery
was uneventful.Discussion
Since two cases of spindle benign tumor of lung were re-
ported by Brunn in 1939 [6], increasing amounts of re-
searchers have paid close attention to this intermediate
type of tumor with low potential malignancy. The World
Health Organization (WHO) classification of tumors of
soft tissue and bone currently defines IMT as a distinctive
neoplasm composed of myofibroblastic and fibroblastic
spindle cells accompanied by an inflammatory infiltrate of
plasma cells, lymphocytes, and/or eosinophils [7]. Most
cases of IMT have been found in the lung, orbit, mesentery
and omentum, and gastrointestinal and genitourinary
tracts [1] in recent years. Several IMTs [8,9] often invade. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 T1-weighted and STIR images in MRI for the lesion. Axial and sagittal T1-weighted image (A, B) show an inhomogeneously
isointense mass in the posterior thigh. The lesion demonstrates inhomogeneously hyperintense on axial and coronal STIR images (C, D).
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To the best of our knowledge, this is the first reported case
of IMT in the lower extremities without bone involvement
and metastasis to other organs.
Extrapulmonary IMTs are more common in children
and young adults with an average age of 10-years-old,
and the incidence of men and women is 1 to 1.4 [2-4],
of which the etiology is unknown. Though reports of post-
surgical, posttraumatic, and postinfectious cases have
prompted speculation that the process is initially reactive,
these patients will fall into an overtly neoplastic disease
category [5].
Patients suffering from IMTs of the thigh have no sys-
temic symptoms (such as anemia, unexplained fever, or
weight loss) or laboratory abnormalities. Besides MRI
scans, histomorphology and immunohistochemical stain-
ing is the most helpful tool in the diagnosis of IMTs.
Furthermore, cytogenetic studies have shown clonal re-
arrangements of the short arm of chromosome 2, involv-
ing the ALK receptor tyrosine kinase locus region, in up
to 50% of soft tissue IMTs [2,10,11]. ALK, a surrogate
for ALK gene rearrangement, has been suggested as a
good immunohistochemical marker for IMT. However,ALK-negative IMTs are indistinguishable histologically
from ALK-positive ones [12]. Our case was negative for
ALK. In recent reports, it has been shown that dediffer-
entiated liposarcoma can have prominent inflammatory
myofibroblastic tumor-like features with expressions of
MDM2 and CDK4 for identification [13,14]. Both markers
MDM2 and CDK4 were not detected in our case. We sug-
gest that the presence or absence of a well-differentiated
liposarcoma component and expressions of MDM2 and
CDK4 should be considered in the diagnosis of IMTs and
requires further research.
Conclusions
In summary, we have reported an additional case of IMT
of the lower extremities without bone involvement. This
was treated with excision, and clinical and histological fea-
tures were consistent with a benign lesion.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Figure 2 Enhanced T1-weighted and T2-weighted images in MRI for the lesion. Axial and coronal enhanced T1-weighted images show
moderate enhancement (A, B). Sagittal T2-weighted image (C) shows an inhomogeneously isointense mass in the posterior thigh.
Figure 3 Photomicrograph by hematoxylin-eosin (HE) and immunohistochemistry staining for tumor. Photomicrograph showing
proliferation of eosinophilic spindle cells with numerous inflammatory cells including lymphocytes and few granulocytes. [HE, original
magnification, ×200] (A). Immunohistochemistry revealed tumor cell immunoreactivity for vimentin (B), smooth muscle actin (SMA) (C), and CD68
(D) (original magnification, ×200).
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